Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1958 1
1960 1
1961 1
1964 1
1965 1
1966 2
1972 1
1975 2
1976 1
1979 1
1980 2
1981 2
1982 2
1983 3
1984 2
1986 1
1987 3
1989 2
1990 3
1995 2
1996 1
1997 1
1998 3
1999 3
2000 2
2002 2
2003 3
2004 1
2006 2
2007 6
2008 4
2009 2
2010 5
2011 3
2012 1
2013 2
2014 9
2015 13
2016 16
2017 15
2018 17
2019 15
2020 20
2021 25
2022 23
2023 17
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Results by year

Filters applied: . Clear all
Page 1
Early Detection of Ovarian Cancer.
Elias KM, Guo J, Bast RC Jr. Elias KM, et al. Hematol Oncol Clin North Am. 2018 Dec;32(6):903-914. doi: 10.1016/j.hoc.2018.07.003. Epub 2018 Sep 28. Hematol Oncol Clin North Am. 2018. PMID: 30390764 Free PMC article. Review.
Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update.
Nelson G, Fotopoulou C, Taylor J, Glaser G, Bakkum-Gamez J, Meyer LA, Stone R, Mena G, Elias KM, Altman AD, Bisch SP, Ramirez PT, Dowdy SC. Nelson G, et al. Among authors: elias km. Gynecol Oncol. 2023 Jun;173:58-67. doi: 10.1016/j.ygyno.2023.04.009. Epub 2023 Apr 21. Gynecol Oncol. 2023. PMID: 37086524 Free article. Review.
Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update.
Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, Taylor JS, Iniesta M, Lasala J, Mena G, Scott M, Gillis C, Elias K, Wijk L, Huang J, Nygren J, Ljungqvist O, Ramirez PT, Dowdy SC. Nelson G, et al. Among authors: elias k. Int J Gynecol Cancer. 2019 May;29(4):651-668. doi: 10.1136/ijgc-2019-000356. Epub 2019 Mar 15. Int J Gynecol Cancer. 2019. PMID: 30877144
Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.
Launonen IM, Lyytikäinen N, Casado J, Anttila EA, Szabó A, Haltia UM, Jacobson CA, Lin JR, Maliga Z, Howitt BE, Strickland KC, Santagata S, Elias K, D'Andrea AD, Konstantinopoulos PA, Sorger PK, Färkkilä A. Launonen IM, et al. Among authors: elias k. Nat Commun. 2022 Feb 11;13(1):835. doi: 10.1038/s41467-022-28389-3. Nat Commun. 2022. PMID: 35149709 Free PMC article.
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer.
Wan C, Keany MP, Dong H, Al-Alem LF, Pandya UM, Lazo S, Boehnke K, Lynch KN, Xu R, Zarrella DT, Gu S, Cejas P, Lim K, Long HW, Elias KM, Horowitz NS, Feltmate CM, Muto MG, Worley MJ Jr, Berkowitz RS, Matulonis UA, Nucci MR, Crum CP, Rueda BR, Brown M, Liu XS, Hill SJ. Wan C, et al. Among authors: elias km. Cancer Res. 2021 Jan 1;81(1):158-173. doi: 10.1158/0008-5472.CAN-20-1674. Epub 2020 Nov 6. Cancer Res. 2021. PMID: 33158814 Free PMC article.
Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles.
Elias K, Smyczynska U, Stawiski K, Nowicka Z, Webber J, Kaplan J, Landen C, Lubinski J, Mukhopadhyay A, Chakraborty D, Connolly DC, Symecko H, Domchek SM, Garber JE, Konstantinopoulos P, Fendler W, Chowdhury D. Elias K, et al. Nat Commun. 2023 Jun 8;14(1):3350. doi: 10.1038/s41467-023-38925-4. Nat Commun. 2023. PMID: 37291133 Free PMC article.
Early Detection of Ovarian Cancer.
Sasamoto N, Elias KM. Sasamoto N, et al. Among authors: elias km. Cold Spring Harb Perspect Med. 2023 Nov 1;13(11):a041337. doi: 10.1101/cshperspect.a041337. Cold Spring Harb Perspect Med. 2023. PMID: 37604591 Review.
Synthetic Lethality in Ovarian Cancer.
Chandrasekaran A, Elias KM. Chandrasekaran A, et al. Among authors: elias km. Mol Cancer Ther. 2021 Nov;20(11):2117-2128. doi: 10.1158/1535-7163.MCT-21-0500. Epub 2021 Sep 13. Mol Cancer Ther. 2021. PMID: 34518297 Free PMC article. Review.
In Reply.
Padrón L, Rezende-Filho J, Amim-Junior J, Sun SY, Cortés-Charry R, Maestá I, Elias KM, Horowitz NS, Braga A, Berkowitz RS. Padrón L, et al. Among authors: elias km. Obstet Gynecol. 2018 Jul;132(1):218. doi: 10.1097/AOG.0000000000002720. Obstet Gynecol. 2018. PMID: 29939922 No abstract available.
235 results